Ambo Agritec Limited has submitted a letter to BSE Limited explaining a delay in filing its Financial Results for the year ended 31st March, 2026. The delay is attributed to a failure to meet the prescribed timeline under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The primary reason cited for the delay is the sudden illness of the company's Chief Financial Officer (CFO). The CFO was suffering from high fever and cough and was advised by a doctor to take complete bed rest for a period of 5 days. The CFO plays a key role in the finalization, review, and certification of the financial statements and results.
Due to the CFO's medical condition and consequent unavailability during the relevant period, the company experienced an unavoidable delay in completing the financial closing process, conducting the internal review, and coordinating the steps required to place the Financial Results before the Board of Directors for approval. This subsequently delayed the submission to the stock exchange.
The company states that the delay was purely unintentional and caused by circumstances beyond its control. It confirms that it has since taken all necessary steps to complete the process and has filed the Financial Results at the earliest possible date. The company expresses regret for the delay and assures its commitment to full regulatory compliance. It also mentions that necessary steps are being taken to strengthen internal processes to prevent such delays from recurring in the future.
The letter is signed by Umesh Kumar Agarwal, Managing Director (DIN: 00210217).